MedTrace Logo

Epidemiological Study in FRONtoTemporal Dementia

NCT05075187 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2287

Last updated 2026-04-09

No results posted yet for this study

Summary

An international, multicenter, epidemiological observational study aims to investigate the prevalence of genetic etiologies in patients diagnosed with FTD or clinically suspected for FTD.

Conditions

  • Frontotemporal Dementia

Interventions

DIAGNOSTIC_TEST

Genetic Screening

Blood samples will be collected from clinically diagnosed or suspected FTD patients and will be analysed for a broad range of pathogenic variants in genes associated with FTD.

Sponsors & Collaborators

  • CENTOGENE GmbH Rostock

    lead INDUSTRY

Principal Investigators

  • Peter Bauer, Ph.D · Centogene GmbH

Eligibility

Min Age
25 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2024-01-09
Completion
2024-01-09

Countries

  • Belgium
  • Germany
  • Greece
  • Italy
  • Portugal
  • Spain
  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05075187 on ClinicalTrials.gov